domperidone has been researched along with ropinirole in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
de Mey, C; Enterling, D; Meineke, I; Yeulet, S | 1 |
Eden, RJ; Parker, SG; Raval, P; Yeulet, S | 1 |
Arnulf, I; Chedru, F; Gauthier, C; Konofal, E | 1 |
Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
1 trial(s) available for domperidone and ropinirole
Article | Year |
---|---|
Interactions between domperidone and ropinirole, a novel dopamine D2-receptor agonist.
Topics: Adult; Blood Pressure; Domperidone; Dopamine Agents; Drug Interactions; Heart Rate; Humans; Indoles; Male; Norepinephrine; Posture; Prolactin; Receptors, Dopamine; Receptors, Dopamine D2 | 1991 |
4 other study(ies) available for domperidone and ropinirole
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Tolerance to peripheral, but not central, effects of ropinirole, a selective dopamine D2-like receptor agonist.
Topics: Administration, Oral; Analysis of Variance; Animals; Bethanidine; Blood Pressure; Bromocriptine; Decerebrate State; Domperidone; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Down-Regulation; Drug Tolerance; Female; Hypertension; Indoles; Injections, Intravenous; Macaca fascicularis; Male; Mesenteric Arteries; Motor Activity; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Dopamine D2; Vasoconstriction | 1994 |
Severe restless legs syndrome presenting as intractable insomnia.
Topics: Chronic Disease; Domperidone; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Indoles; Iron; Male; Middle Aged; Restless Legs Syndrome; Sleep Apnea Syndromes; Sleep Initiation and Maintenance Disorders; Sleep Stages | 2004 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |